Intrabio Inc company information, Employees & Contact Information

Pharma start-up IntraBio and CEO Mallory Factor patently mean business IAM Patent

IntraBio Inc. Completes Recruitment for IB1001 A-T Pivotal Clinical Trial BioSpace

AQNEURSA® (levacetylleucine) Recommended for EU Approval by the CHMP to Treat Niemann-Pick Disease Type C BioSpace

N-Acetyl-L-Leucine Reduces Disease Progression in Phase 2 Extension Study for Ataxia-Telangiectasia NeurologyLive

IntraBio Announces U.S. FDA Accepts New Drug Application for IB1001 for the Treatment of Niemann-Pick Disease Type C Yahoo Finance

How IntraBio's finance transformation fueled its global expansion EY

IntraBio Announces U.S. FDA Approval of AQNEURSA for the Treatment of Niemann-Pick Disease Type C Business Wire

FDA Approves Levacetylleucine for Niemann-Pick Disease Type C HCPLive

US FDA approves IntraBio's drug for rare genetic disease Reuters

Austin's IntraBio accelerates hope for rare neurological disease treatment KEYE

IntraBio muscles in on Zevra's turf after companies' back-to-back lysosomal storage disorder nods Fierce Pharma

IntraBio Update Yahoo Finance

After landmark rare disease approval, IntraBio ready to 'hit the ground running' with Aqneursa launch Fierce Pharma

FDA Approves Stand-Alone Therapy Levacetylleucine for Niemann-Pick Disease Type C NeurologyLive

Curant Health Selected By IntraBio as the Exclusive Specialty Pharmacy for AQNEURSA Business Wire

IntraBio Wins FDA Nod for Ultra-Rare Neurodegenerative Disease on Heels of Competitor’s Approval BioSpace

Fractus IoT enforcement; Ericsson Q3 results; IntraBio CEO interview; Samsung ETSI complaint order; UK SEP proposal kickback; plus much more IAM Patent

Take your (Niemann-) Pick: Intrabio’s Aqneursa wins FDA nod BioWorld MedTech

Quince Therapeutics Updates on IntraBio Phase 2 Study TradingView

UK biopharma company IntraBio moves HQ to Austin, raises $40M The Business Journals

Acetylation turns leucine into a drug by membrane transporter switching Nature

FDA Approves First Treatments for Niemann-Pick Disease Type C NAVLIN DAILY

FDA Approves Levacetylleucine for Treatment of Niemann-Pick Disease Type C Drug Topics

EY Unveils Finance Service Built on SAP Cloud Technology FinTech Magazine

N-acetyl-L-leucine improves symptoms and functioning in GM2 Gangliosidosis (Tay-Sachs & Sandhoff) medRxiv

IntraBio Receives Niemann-Pick Disease European Orphan Drug Designation drugdiscoverytrends.com